Atlas Trials

A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy

Clinical trial NCT00644748 · COMPLETED

Trial details

NCT number
NCT00644748
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Neuropathies
Start date
2003-05-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.